Michael Shetzline Net Worth & Insider Trades

Michael Shetzline - CMOSVP,Head-Res&Drug, Ironwood Pharmaceuticals Inc

As of May 24, 2023

What is Michael Shetzline's Net Worth?

The current estimated net worth of Ironwood Pharmaceuticals Inc's CMOSVP,Head-Res&Drug, Michael Shetzline, is estimated to be about $2.01M . Michael Shetzline owns about 321,131 units of Ironwood Pharmaceuticals Inc common stock. In the last 3 years at Ironwood Pharmaceuticals Inc, Michael Shetzline has sold an estimated value of $860.7K worth.

What is Michael Shetzline's Past Insider Trading?

Michael Shetzline's largest sale order was 19,322 units , worth over $219.48K on March 1, 2023. In total, Michael Shetzline has made about 14 transactions over 3 years of their time at Ironwood Pharmaceuticals Inc. Michael Shetzline usually trades in March, with the busiest year in 2021. The most recent transaction was a sale order of 10,324 units , worth over $104.48K on May 24, 2023.

Michael Shetzline

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What was Michael Shetzline's Salary in 2020?

As CMOSVP,Head-Res&Drug of Ironwood Pharmaceuticals Inc, Michael Shetzline has a total base salary of $464,681 . Michael Shetzline received compensation valued at about $1,891,310 in 2020 after becoming CMOSVP,Head-Res&Drug. The vast majority of their compensation came in the form of a bonus of $100,000 , stock awards of $1,121,001 , other earnings, plans or compensations of $194,558 , and other compensation of $11,040 .

What is Michael Shetzline's' Mailing Address?

  • Mailing address is 100 Summer Street, Suite 2300 Boston MA 02110 MA

Ironwood Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Mark Mallon* 2020 $801,173 - $5,423,731 - $585,169 $11,040 $6,821,113
Mark Mallon* 2019 $750,000 $880,000 $3,692,810 $3,804,331 $797,063 $144,596 $10,068,800
Mark Mallon* 2018 - - - - - - -
Gina Consylman 2020 $512,751 - $1,676,402 - $264,652 $11,040 $2,464,845
Gina Consylman 2019 $480,000 $250,000 $1,467,731 $888,546 $358,800 $8,502 $3,453,579
Gina Consylman 2018 $415,000 - $782,385 $501,764 $207,500 $8,040 $1,914,688
Thomas McCourt* 2020 $576,120 - $2,465,327 - $357,409 $11,040 $3,409,896
Thomas McCourt* 2019 $511,250 - $1,760,143 $2,370,159 $454,272 $8,502 $5,104,327
Thomas McCourt* 2018 $465,000 - $549,641 $869,479 $232,500 $34,002 $2,150,622
Jason Rickard 2020 $473,314 - $1,479,191 - $258,338 $11,040 $2,221,883
Jason Rickard 2019 - - - - - - -
Jason Rickard 2018 - - - - - - -
Michael Shetzline, M.D., Ph.D. 2020 $464,681 $100,000 $1,121,001 - $194,558 $11,040 $1,891,310
Michael Shetzline, M.D., Ph.D. 2019 - - - - - - -
Michael Shetzline, M.D., Ph.D. 2018 - - - - - - -
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1446847/000104746921001006/a2243150zdef14a.htm

What are Ironwood Pharmaceuticals Inc's Past Insider Trades?

Ironwood Pharmaceuticals Inc's most recent insider trade came on June 1, 2023 by Thomas McCourt who sold 26,632 units worth $284.96K . In the last 13 years, insiders at Ironwood Pharmaceuticals Inc have sold an estimated value of $119.28M and bought an estimated value of $42.1M worth of shares. Insider trading is most common in March, with the busiest year in 2019. The most active traders at the company are Mark Currie, Director,  Thomas McCourt, Chief Executive Officer,  and Bryan E Roberts, Director .

IRONWOOD PHARMACEUTICALS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...